Search Results

Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature.

• Authors : Kitkunvan, Danai; Apisanthanarak, Anucha; Plengpart, Panarat

Subjects: HIV-positive persons; AIDS patients; ETIOLOGY of diseasesTHAILAND

• Source: International Journal of STD & AIDS; Apr2008, Vol. 19 Issue 4, p232-235, 4p, 4 Charts

Record details

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

• Authors : Arterial Remodeling Technologies

• Source: Business Wire (English). 10/28/2013.

Record details

Arterial Remodeling Technologies (“ART”) Reports First Human Use of Its Next-Generation Bioresorbable Stent

• Authors : Arterial Remodeling Technologies

• Source: Business Wire (English). 07/16/2012.

Record details

Arterial Remodeling Technologies ('ART') reports 30-day results for the 'ARTDIVA' clinical trial of its next-generation bioresorbable stent at 'TCT 2013' annual scientific meeting

• Authors : By:Ronald Trahan Associates Inc.; Ronald Trahan, APR,

• Source: Business Wire, October 28, 2013, 2pp

Record details

Arterial Remodeling Technologies ("ART") Reports First Human Use of Its Next-Generation Bioresorbable Stent

• Authors : By:Ronald Trahan Associates Inc.; Ronald Trahan, APR,

• Source: Business Wire, July 16, 2012, 2pp

Record details

Antiretroviral Therapy: When to Start

• Authors : Glesby Marshall; Singh Harjot

• Source: Encyclopedia of AIDS.

Record details

NK cells in HIV infection: Paradigm for protection or targets for ambush.

• Authors : Fauci, Anthony S.; Mavilio, Domenico; Kottilil, Shyam

• Source: Nature Reviews Immunology. November, 2005, Vol. 5 Issue 11, p835, 9 p.

Record details

Findings from University of Texas Provide New Insights into HIV/AIDS (CROI 2019: advances in antiretroviral therapy)

• Source: AIDS Weekly. July 15, 2019, 56

Record details

Arterial Remodeling Technologies 'ART' Reports First Human Use of Its Next-Generation Bioresorbable Stent

• Source: Obesity, Fitness & Wellness Week. August 4, 2012, 141

Record details

Arterial Remodeling Technologies 'ART' reports 30-day results for the 'ARTDIVA' clinical trial of its next-generation bioresorbable stent at 'TCT 2013' annual scientific meeting

• Source: Clinical Trials Week. November 11, 2013, 48

Record details